Ueli Nachbur
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
ZnF-UBP domains regulate deubiquitinase activity by relieving ubiquitin product inhibition.
Journal: Nature communications
Published: October 04, 2025
A novel PLpro inhibitor improves outcomes in a pre-clinical model of long COVID.
Journal: Nature communications
Published: December 18, 2024
MLKL deficiency protects against low-grade, sterile inflammation in aged mice.
Journal: Cell death and differentiation
Published: October 12, 2022
Insights Into Drug Repurposing, as Well as Specificity and Compound Properties of Piperidine-Based SARS-CoV-2 PLpro Inhibitors.
Journal: Frontiers in chemistry
Published: January 24, 2022
Potent Inhibition of Necroptosis by Simultaneously Targeting Multiple Effectors of the Pathway.
Journal: ACS chemical biology
Published: September 09, 2020
A regulatory region on RIPK2 is required for XIAP binding and NOD signaling activity.
Journal: EMBO reports
Published: March 11, 2020
Oligomerization-driven MLKL ubiquitylation antagonizes necroptosis.
Journal: The EMBO journal
Published: October 14, 2019
NOD Signaling and Cell Death.
Journal: Frontiers in cell and developmental biology
Published: June 05, 2019
XIAP controls RIPK2 signaling by preventing its deposition in speck-like structures.
Journal: Life science alliance
Published: February 14, 2019
Last Updated: 09/26/2026